BEAT THE STREET GAME:
Bristol Sells ConvaTec Unit for $4.1 Billion
A group of pricate equity firms is buying the wound care business in a deal expected to close in the third quarter.
Related Topics: Health Care | Drugs
04:54PM 05/02/08
Friday's Winners & Losers: Yahoo!
Shares rise 6.9% on more merger rumors.
Related Topics: Drugs | Financial Services | Internet | Aerospace/Defense | Winners & Losers
04:25PM 05/02/08
FDA Approval Delay Sinks Discovery Labs
Surfaxin receives an approvable letter, but the additional delays that accompany it send shares plummeting in premarket trading.
Related Topics: Health Care | Drugs
08:22PM 05/01/08
Altucher: End-of-the-World Stocks
By James Altucher | By Farnoosh Torabi
James Altucher describes winning stocks for a doomed planet.
Related Topics: Food and Beverage | Markets | Drugs | Technology | Media | Energy | Financial Services
11:52AM 05/01/08
Thursday's Analysts' Upgrades, Downgrades
By TheStreet.com Ratings Staff
See who made what calls.
Related Topics: Industrials | Drugs | Real Estate | Analyst Upgrades/Downgrades | Autos | Energy | Technology | Food and Beverage
09:08AM 05/01/08
Wednesday's Winners & Losers: Buffalo Wild Wings
Shares soar 22% after the company announces in-line earnings.
Related Topics: Winners & Losers | Health Care | Technology | Food and Beverage | Drugs
04:29PM 04/30/08
Biotech Notebook: Progenics, Wyeth, Introgen
Projecting potential market share for newly approved Relistor; monitoring exec moves at Introgen; and more.
Related Topics: Biotech | Health Care | Drugs
09:26AM 04/30/08
Discovery Labs Awaits FDA Word on Surfaxin
A regulatory decision on the lung treatment could come May 1, but even with approval the biotech will have to work for every bit of upside.
Related Topics: Biotech | Health Care | Drugs
02:02PM 04/29/08
Merck Tumbles After FDA Rejects Drug
Shares are falling 8% as the agency turns down an application for a new cholesterol treatment.
Related Topics: Health Care | Drugs
10:12AM 04/29/08
Another Rituxan Setback for Biogen, Genentech
The drug failed to benefit patients with lupus, according to new late-stage study data.
Related Topics: Biotech | Drugs | Health Care
10:12AM 04/29/08
Vertex Hep C Drug Still Leads Schering
Data presented this weekend show telaprevir is the leader.
Related Topics: Drugs | Biotech | Health Care
08:47PM 04/27/08
Feuerstein's Biotech-Stock Mailbag
What to expect when ImClone presents the latest Erbitux data at ASCO in June.
Related Topics: Biotech | Health Care | Drugs
09:57AM 04/26/08
Friday's Winners & Losers: Progenics
Shares rise 26.8% after the company gets U.S. approval for Relistor.
Related Topics: Telecom | Health Care | Drugs | Software | Winners & Losers | Technology
04:28PM 04/25/08
FDA Delays Hit Genzyme, Isis JV Deal
Regulatory demands will result in delays for cholesterol-lowering candidate Mipomersen. Isis gets a downgrade on the news.
Related Topics: Health Care | Biotech | Drugs
12:31PM 04/25/08
Kass: Stop Pointing Fingers at Short-Sellers
Several corporate managements continue to blame short sellers for their own fundamental mistakes.
Related Topics: Internet | Retail | Financial Services | Health Care | Real Estate | Fundamental Analysis | Stock Picks | Insurance | Drugs | Banks | Implied Volatility
11:59AM 04/25/08
symbol throughout our site to look up items.
